Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 124

    1.

    Hepatocellular injury in a patient receiving rosiglitazone. A case report.

    Al-Salman J, Arjomand H, Kemp DG, Mittal M.

    Ann Intern Med. 2000 Jan 18;132(2):121-4. Erratum in: Ann Intern Med 2000 Aug 1;133(3):237. PMID: 10644273 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Mixed hepatocellular-cholestatic liver injury after pioglitazone therapy.

    May LD, Lefkowitch JH, Kram MT, Rubin DE.

    Ann Intern Med. 2002 Mar 19;136(6):449-52.PMID: 11900497 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Hepatic failure in a patient taking rosiglitazone.

    Forman LM, Simmons DA, Diamond RH.

    Ann Intern Med. 2000 Jan 18;132(2):118-21.PMID: 10644272 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Severe cholestatic hepatitis caused by thiazolidinediones: risks associated with substituting rosiglitazone for troglitazone.

    Bonkovsky HL, Azar R, Bird S, Szabo G, Banner B.

    Dig Dis Sci. 2002 Jul;47(7):1632-7.PMID: 12141828 [PubMed - indexed for MEDLINE]Related articles

    5.

    Hepatotoxicity with thiazolidinediones: is it a class effect?

    Scheen AJ.

    Drug Saf. 2001;24(12):873-88. Review.PMID: 11735645 [PubMed - indexed for MEDLINE]Related articles

    6.

    Evaluation of liver function in type 2 diabetic patients during clinical trials: evidence that rosiglitazone does not cause hepatic dysfunction.

    Lebovitz HE, Kreider M, Freed MI.

    Diabetes Care. 2002 May;25(5):815-21.PMID: 11978674 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Rosiglitazone-induced granulomatous hepatitis.

    Dhawan M, Agrawal R, Ravi J, Gulati S, Silverman J, Nathan G, Raab S, Brodmerkel G Jr.

    J Clin Gastroenterol. 2002 May-Jun;34(5):582-4.PMID: 11960075 [PubMed - indexed for MEDLINE]Related articles

    8.

    [Severe electrolyte imbalance and edema in therapy with rosiglitazone]

    Kuschel U, Hesselbarth N, Herrmann A, Hippius M, Hoffmann A.

    Med Klin (Munich). 2002 Sep 15;97(9):553-5. German. PMID: 12371084 [PubMed - indexed for MEDLINE]Related articles

    9.

    Effect of metformin and rosiglitazone combination therapy in patients with type 2 diabetes mellitus: a randomized controlled trial.

    Fonseca V, Rosenstock J, Patwardhan R, Salzman A.

    JAMA. 2000 Apr 5;283(13):1695-702. Erratum in: JAMA 2000 Sep 20;284(11):1384. PMID: 10755495 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Second-generation thiazolidinediones and hepatotoxicity.

    Marcy TR, Britton ML, Blevins SM.

    Ann Pharmacother. 2004 Sep;38(9):1419-23. Epub 2004 Jul 20.PMID: 15266041 [PubMed - indexed for MEDLINE]Related articles

    11.

    Troglitazone-induced hepatic failure leading to liver transplantation. A case report.

    Neuschwander-Tetri BA, Isley WL, Oki JC, Ramrakhiani S, Quiason SG, Phillips NJ, Brunt EM.

    Ann Intern Med. 1998 Jul 1;129(1):38-41.PMID: 9652998 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    [Medication of the month. Rosiglitazone (Avandia)]

    Scheen AJ.

    Rev Med Liege. 2002 Apr;57(4):236-9. Review. French. PMID: 12073798 [PubMed - indexed for MEDLINE]Related articles

    13.

    Chronic heart failure-related interventions after starting rosiglitazone in patients receiving insulin.

    Marceille JR, Goins JA, Soni R, Biery JC, Lee TA.

    Pharmacotherapy. 2004 Oct;24(10):1317-22.PMID: 15628829 [PubMed - indexed for MEDLINE]Related articles

    14.

    Hepatocellular injury in a patient receiving pioglitazone.

    Maeda K.

    Ann Intern Med. 2001 Aug 21;135(4):306. No abstract available. PMID: 11511159 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus.

    Wagstaff AJ, Goa KL.

    Drugs. 2002;62(12):1805-37. Review.PMID: 12149047 [PubMed - indexed for MEDLINE]Related articles

    16.

    Thiazolidinediones and liver toxicity.

    Scheen AJ.

    Diabetes Metab. 2001 Jun;27(3):305-13. Review.PMID: 11431595 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Severe but reversible hepatitis induced by troglitazone.

    Schiano T, Dolehide K, Hart J, Baker AL.

    Dig Dis Sci. 2000 May;45(5):1039-42. No abstract available. PMID: 10795774 [PubMed - indexed for MEDLINE]Related articles

    18.

    Possible metformin-induced hepatotoxicity.

    Kutoh E.

    Am J Geriatr Pharmacother. 2005 Dec;3(4):270-3.PMID: 16503324 [PubMed - indexed for MEDLINE]Related articles

    19.

    A review of rosiglitazone in type 2 diabetes mellitus.

    Werner AL, Travaglini MT.

    Pharmacotherapy. 2001 Sep;21(9):1082-99. Review.PMID: 11560198 [PubMed - indexed for MEDLINE]Related articles

    20.

    Rosiglitazone in Type 2 diabetes mellitus: an evaluation in British Indo-Asian patients.

    Barnett AH, Grant PJ, Hitman GA, Mather H, Pawa M, Robertson L, Trelfa A; Indo-Asian Trial Investigators.

    Diabet Med. 2003 May;20(5):387-93.PMID: 12752488 [PubMed - indexed for MEDLINE]Related articles